Author(s): Chukwuemeka I. MBAM, Chinwe O. EWENIGHI-AMANKWAH, Godwin O. OKORO, Samuel A. FASOGBON, Cyril A. EGBO, Nnenna I. NJOKU, Kabiru O. AYODELE, Ifeoma G. ONUKWUE, Loveth O. FASOGBON, Sumbola A. ADEYINKA, Ahmed O. ADEBAYO, Dayo E. ADEDIWURA, Damilola E. OGUNTUNNBI, Ayobami B. OLAYERA
Background: Cortisol is a steroid hormone, in the glucocorticoid class of hormones that functions to increase blood sugar through gluconeogenesis. Diabetogenic hormones such as cortisol play a role in the complications of diabetes mellitus and abnormally high cortisol exerts anti-insulin effect that leads to reduction in insulin sensitivity which is a major factor contributing to development of type2 diabetes mellitus. Aim: This study aimed at evaluating the serum level of Cortisol in type-2 diabetes mellitus patients. Materials and Methods: Samples from thirty (30) confirmed drug treated type2 diabetic subjects attending clinic at federal teaching hospital Abakaliki and fifteen (15) non-diabetic volunteers were analyzed of serum cortisol level using enzyme linked immunosorbent assay (ELISA) method. The data generated was analyzed using statistical software IBM SPSS version 20.0. The results were expressed as mean+ SEM. Data from this study was analyzed using T-paired test analysis. Results and Discussion: This study showed that the serum cortisol level was normal and had no significant difference (p=0.13) in treated type2 diabetic subjects (2.94+0.73nmol/l) compared to that of the control subjects (1.83+0.06). Also, the mean levels of serum cortisol in comparison with the duration of treatment showed that type2 diabetic subjects with treatment duration of 1-2years showed higher significant difference (P=0.03) in their mean levels of cortisol (2.51+0.54) compared to subjects with treatment duration of 6-10years (0.82+0.05). Conclusion: Serum cortisol level in a well drug treated type2 diabetic subjects was observed to be normal with an inverse correlation with duration of treatment.
Cortisol, Diabetic Mellitus, Insulin, Treatment, Type-2
- Alberti, K.G.M., Zimmet, P.Z., (2004). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetes Medical journal, 15: 539-553.
- David R Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw (2011). IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94(3): 311-321.
- Kengne AP, Amoah AG, Mbanya JC. (2005); Cardiovascular complications of diabetes mellitus in sub-Saharan Africa, Journal ofCirculation, 112:3592–3601.
- Oputa, R. N. and Chinenye S. (2015). Diabetes in Nigeria – a translational medicine approach. African Journal of Diabetes Medicine. 23 (1): 496
- United Nation (2017). A United Nations Resolution on Diabetes The Result of a Joint Effort. https://www.touchendocrinology.com/diabetes/journal-articles/a-united-nations-resolution-on-diabetes-the-result-of-a-joint-effort Cited 12/10/2019
- WHO (2012). Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes Cited 22/11/2018
- Stumvoll M., Goldstein BJ, van Haeften TW. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet; 9467: 1333–1346
- Oswald LM, Zandi P, Nestadt G, Potash JB, Kalaydjian AE, Wand GS. (2006). Relationship between cortisol response to stress and personality. Neuropsychopharmacology; 31:1583–1591.
- Hoehn K. and Marieb EN (2010). Human Anatomy & Physiology. San Francisco: Benjamin Cummings. ISBN 978-0-321-60261-9.
- Tracey, L. (2010). The Role of Cortisol and Abdominal Obesity in the Epidemic of Type 2 Diabetes. University of Pennsylvania, Volume 9. https://www.kon.org/urc/v9/liebman.html? Retrieved 10/03/2021
- Bruehl H., Oliver T. Wolf, and Antonio C. (2009). A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology. 34(6): 815–821.
- F Lederbogen, J Hummel, C Fademrecht, B Krumm, C Kühner, M Deuschle, K-H Ladwig, C Meisinger, H-E Wichmann, H Lutz, and B Breivogel (2011). Flattened circadian cortisol rhythm in type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes. 119(9):573-575.
- Julie Polisena, Doug Coyle, Kathryn Coyle, Sarah McGill (2009). Home telehealth for chronic disease management: a systematic review and an analysis of economic evaluations. International Journal of Technology Assessment in Health Care; 25(3):339-349
- Mohammad, A. (2014). The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. Journal of Education and Health Promotion; 3: 1
- Lisa A., Neda RE., Charlotte H., Kerstin B., Michael A. (2013); Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance, Journal of clinical Endocrinology and Metabolism 84; 2167-7948.
- Kota N, Noriko F., Kanako M, Yuko O, Rei H, Yasuhiro H, Mei U, Taro Y, Toshinari S, Corina N, D'Alessandro-G, Yutaka Y, Esteban CG. (2018); canagliflozin improves obesity and insulin resistance in a diabetic patient with Cushings disease undergoing postoperative steroid therapy: A case report, journal of Biomedical Report, 9(6): 497–502.
- Isaac A, Ibrahim Y, Andrew A, Ibrahim Y, Edward D, Solomon A (2017) The Cortisol Steroid Levels as a Determinant of Health Status in Animals. J Proteomics Bioinform 10: 277-283. doi: 10.4172/jpb.1000452
- Gallagher P, Leitch MM, Massey AE, McAllister Williams RH, Young AH (2006) Assessing cortisol and dehydro-epiandrosterone (DHEA) in saliva: effects of collection method. J Psychopharmacol. 20: 643-649.
Cite this Article:
International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.